Mark Shephard

2.1k citations

100 papers · 1.4k indexed · h-index 25

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Education
Nephrology top 5%
- Chronic Kidney Disease and Diabetes

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 31
- Diabetes, Cardiovascular Risks, and Lipoproteins 23
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 12
- Diabetes Management and Research 10
Physiology 30
- Clinical Laboratory Practices and Quality Control 22
- Syphilis Diagnosis and Treatment 7

Co-authors: Beryl Mazzachi (10 shared papers)Janice Gill (6 shared papers)M.J. Whiting (3 shared papers)Callum G. Fraser (6 shared papers)M J Peake (3 shared papers)Malcolm J. Whiting (3 shared papers)Rebecca Guy (14 shared papers)George A. Tallis (4 shared papers)
Journals: Rural and Remote Health (7 papers)Annals of Clinical Biochemistry International Journal of Laboratory Medicine (7 papers)Pathology (6 papers)Journal of Clinical Pathology (5 papers)The Medical Journal of Australia (5 papers)
Partner nations: Australia United States Timor-Leste

In The Last Decade

Mark Shephard

94 papers receiving 1.4k citations

Peers

Countries citing papers authored by Mark Shephard

Since Specialization

Citations

This map shows the geographic impact of Mark Shephard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shephard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shephard more than expected).

Fields of papers citing papers by Mark Shephard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Shephard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shephard. The network helps show where Mark Shephard may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Shephard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Shephard Line = papers co-authored together Mark Shephard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities Clinica Chimica Acta ·Tomer Shemesh, Kevin Rowley, Mark Shephard, Leonard S. Piers, Kerin O’Dea	2006	61
2	Screening for chronic kidney disease in Australia: a pilot study in the community and workplace Kidney International ·Timothy H. Mathew, Olivia Corso, Marie Ludlow, Adam Boyle, Alan Cass, Steven J. Chadban, Beres Joyner, Mark Shephard, Tim Usherwood	2010	50
3	A decentralised point-of-care testing model to address inequities in the COVID-19 response The Lancet Infectious Diseases ·Belinda Hengel, Louise Causer, Susan Matthews, Kirsty Smith, Kelly Andrewartha, Steven G. Badman, Brooke Spaeth, Annie Tangey, Philip Cunningham, Amit Saha, Emily Phillips, James Ward, Caroline G. Watts, Jonathan King, Tanya Applegate, Mark Shephard, Rebecca Guy	2020	49
4	The impact of point of care testing on diabetes services along Victoria's Mallee Track: Results of a community-based diabetes risk assessment and management program Rural and Remote Health ·Mark Shephard, Beryl Mazzachi, Anne Shephard, Kristin McLaughlin, Bernard J Denner BJ, Glennis Barnes	2005	48
5	Comparative performance of two point-of-care analysers for lipid testing. PubMed ·Mark Shephard, Beryl Mazzachi, Anne Shephard	2007	45
6	Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder's chromogen Clinical Chemistry ·Mark Shephard, M.J. Whiting	1990	44
7	Cultural and clinical effectiveness of the 'QAAMS' point-of-care testing model for diabetes management in Australian aboriginal medical services. PubMed ·Mark Shephard	2006	41
8	A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting – rationale, design and baseline characteristics Trials ·Caroline Laurence, Angela Gialamas, Lisa N Yelland, Tanya Bubner, Philip Ryan, Kristyn Willson, Briony Glastonbury, Janice Gill, Mark Shephard, Justin Beilby	2008	39
9	A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the “TTANGO” trial protocol BMC Infectious Diseases ·Rebecca Guy, Lisa Natoli, James Ward, Louise Causer, Belinda Hengel, David M. Whiley, Sepehr N. Tabrizi, Basil Donovan, Christopher K. Fairley, Steven G. Badman, Annie Tangey, Handan Wand, Mark Shephard, David G. Regan, David P. Wilson, David A. Anderson, John M Kaldor	2013	36
10	Evaluation of an enzymatic method for determining creatinine in plasma. Journal of Clinical Pathology ·Helen Crocker, Mark Shephard, G H White	1988	36
11	“I Do Feel Like a Scientist at Times”: A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting PLoS ONE ·Lisa Natoli, Rebecca Guy, Mark Shephard, Louise Causer, Steven G. Badman, Belinda Hengel, Annie Tangey, James Ward, Tony Coburn, David A. Anderson, John Kaldor, Lisa Maher, (unknown)	2015	35
12	Short- and long-term biological variation in analytes in urine of apparently healthy individuals. Clinical Chemistry ·Mark Shephard, L A Penberthy, Callum G. Fraser	1981	35
13	Point‐of‐care testing of HbA1c and blood glucose in a remote Aboriginal Australian community The Medical Journal of Australia ·David Martín, Timothy W. Jones, Elizabeth A. Davis, Mark Shephard, Hayley Freeman, Graeme Maguire, Max Bulsara	2005	33
14	An Aboriginal-driven program to prevent, control and manage nutrition-related "lifestyle" diseases including diabetes. PubMed ·Michael Gracey, Ernie Bridge, David Martín, Timothy W. Jones, Randolph M. Spargo, Mark Shephard, Elizabeth A. Davis	2006	33
15	Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation Sexually Transmitted Infections ·Louise Causer, Rebecca Guy, Sepehr N. Tabrizi, David M. Whiley, David Speers, James Ward, Annie Tangey, Steven G. Badman, Belinda Hengel, Lisa Jane Natoli, David A. Anderson, Handan Wand, David P. Wilson, David G. Regan, Mark Shephard, Basil Donovan, Christopher K. Fairley, John Kaldor	2018	32
16	Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease Clinical Chemistry and Laboratory Medicine (CCLM) ·Mark Shephard, M J Peake, Olivia Corso, Anne Shephard, Beryl Mazzachi, Brooke Spaeth, J. A. J. Barbara, Timothy H. Mathew	2010	31
17	Point-of-care testing improves diabetes management in a primary care clinic in South Africa Primary care diabetes ·Lara A. Motta, Mark Shephard, Julie Brink, Stefan Lawson, Paul Rheeder	2017	29
18	Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care Rural and Remote Health ·Brooke Spaeth, Mark Shephard, Steven Schatz	2014	29
19	Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial The Lancet Infectious Diseases ·Rebecca Guy, James Ward, Louise Causer, Lisa Natoli, Steven G. Badman, Annie Tangey, Belinda Hengel, Handan Wand, David M. Whiley, Sepehr N. Tabrizi, Mark Shephard, Christopher K. Fairley, Basil Donovan, David A. Anderson, David G. Regan, Lisa Maher, John Kaldor	2018	28
20	Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices Rural and Remote Health ·Mark Shephard, Beryl Mazzachi, Les Watkinson, Anne Shephard, Caroline Laurence, Angela Gialamas, Tanya Bubner	2009	28

About Mark Shephard

Mark Shephard is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Epidemiology, Public Health, Environmental and Occupational Health and General Health Professions, having authored 100 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Clinical Laboratory Practices and Quality Control (22 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (12 papers), Diabetes Management and Research (10 papers), Ethics in Clinical Research (10 papers), Chronic Kidney Disease and Diabetes (10 papers), Reproductive tract infections research (9 papers) and Syphilis Diagnosis and Treatment (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (366 citations), Nephrology (146 citations), Microbiology (113 citations), Family Practice (37 citations) and Physiology (354 citations). Mark Shephard has collaborated with scholars based in Australia, United States and Timor-Leste. Frequent co-authors include Beryl Mazzachi, Janice Gill, M.J. Whiting, Callum G. Fraser, M J Peake, Malcolm J. Whiting, Rebecca Guy, George A. Tallis, Steven G. Badman and James Ward. Their work appears in journals such as Rural and Remote Health, Annals of Clinical Biochemistry International Journal of Laboratory Medicine, Pathology, Journal of Clinical Pathology and The Medical Journal of Australia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact